✦ LIBER ✦

Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: Final report of rtog phase I/II study

✍ Scribed by William J. Spanos Jr.; Todd Wasserman; Raul Meoz; Jose Sala; Joseph Kong; Joann Stetz R.N.

Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 465 KB
Volume: 13
Category: Article
ISSN: 0360-3016
DOI: 10.1016/0360-3016(87)90314-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Palliation of advanced pelvic malignanci

Palliation of advanced pelvic malignancies with large fraction pelvic radiation and misonidazole: Final report of RTOG phase 1–11 study

✍ William J. Spanos Jr.; Richard Johnson; Jose Sala; Joseph Kong; JoAnn Stetz 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Phase II study of multiple daily fractio

Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: Preliminary report of RTOG 8502

✍ William Spanos Jr.; Claire Guse; Carlos Perez; Perry Grigsby; R.L.S. Doggett; Co 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Phase II study of multiple daily fractio

Phase II study of multiple daily fractionations in the palliation of advanced pelvic malignancies: Preliminary report of RTOG 8502

✍ William Spanos Jr.; Claire Guse; Carlos Perez; Perry Grigsby; R.L.S. Doggett; Co 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Effect of rest interval on tumor and nor

Effect of rest interval on tumor and normal tissue response—A report of phase III study of accelerated split course palliative radiation for advanced pelvic malignancies (RTOG-8502)

✍ William J. Spanos Jr.; Carlos A. Perez; Sue Marcus; Colin A. Poulter; R.L.Scotte 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 522 KB

Final report of a phase I/II trial of hy

Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas: Radiation therapy oncology group study 83-02

✍ Maria Werner-Wasik; Charles B. Scott; Diana F. Nelson; Laurie E. Gaspar; Kevin J 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

## BACKGROUND. Efforts to improve local control and survival by increasing the dose of once-daily radiation therapy beyond 70 Gray (Gy) for patients with malignant gliomas have as yet been unsuccessful. Hyperfractionated radiation therapy (HF) should allow for delivery of a higher total dose witho